GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,497,000 | -99.3% | 6,901 | -99.6% | 0.00% | -98.9% |
| Q4 2020 | $221,975,000 | +2.1% | 1,923,359 | -13.8% | 0.09% | -10.5% |
| Q3 2020 | $217,311,000 | -22.7% | 2,232,259 | +6.4% | 0.10% | -27.6% |
| Q2 2020 | $280,966,000 | +35.3% | 2,097,699 | -11.6% | 0.14% | +4.3% |
| Q1 2020 | $207,678,000 | -13.4% | 2,371,792 | +3.4% | 0.14% | +10.3% |
| Q4 2019 | $239,736,000 | +14.2% | 2,293,031 | +25.6% | 0.13% | +10.5% |
| Q3 2019 | $209,998,000 | -29.8% | 1,825,511 | +5.3% | 0.11% | -28.3% |
| Q2 2019 | $298,986,000 | +49.1% | 1,734,445 | +45.8% | 0.16% | +48.6% |
| Q1 2019 | $200,461,000 | +1395.4% | 1,189,251 | +1432.5% | 0.11% | +1428.6% |
| Q3 2018 | $13,405,000 | -1.0% | 77,603 | -20.1% | 0.01% | 0.0% |
| Q2 2018 | $13,545,000 | -5.5% | 97,070 | -23.7% | 0.01% | 0.0% |
| Q1 2018 | $14,340,000 | -38.1% | 127,270 | -27.4% | 0.01% | -36.4% |
| Q4 2017 | $23,151,000 | -8.1% | 175,370 | -29.3% | 0.01% | -8.3% |
| Q3 2017 | $25,187,000 | +1.2% | 248,170 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $24,879,000 | -29.5% | 248,170 | -15.0% | 0.01% | -33.3% |
| Q1 2017 | $35,311,000 | -27.9% | 291,970 | -33.4% | 0.02% | -28.0% |
| Q4 2016 | $48,999,000 | -13.0% | 438,470 | +3.4% | 0.02% | -13.8% |
| Q3 2016 | $56,300,000 | +104.8% | 424,170 | +41.3% | 0.03% | +93.3% |
| Q2 2016 | $27,487,000 | +246.4% | 300,170 | +173.0% | 0.02% | +275.0% |
| Q1 2016 | $7,934,000 | +3.8% | 109,970 | -0.1% | 0.00% | 0.0% |
| Q4 2015 | $7,641,000 | -24.2% | 110,045 | -0.2% | 0.00% | -20.0% |
| Q3 2015 | $10,076,000 | -62.3% | 110,274 | -49.4% | 0.01% | -58.3% |
| Q2 2015 | $26,751,000 | +24.8% | 217,774 | -7.4% | 0.01% | +20.0% |
| Q1 2015 | $21,440,000 | +34.6% | 235,270 | 0.0% | 0.01% | +42.9% |
| Q4 2014 | $15,923,000 | -15.4% | 235,270 | +1.1% | 0.01% | -22.2% |
| Q3 2014 | $18,819,000 | -60.7% | 232,770 | -47.9% | 0.01% | -57.1% |
| Q2 2014 | $47,945,000 | +71.3% | 446,870 | -5.2% | 0.02% | +61.5% |
| Q1 2014 | $27,993,000 | – | 471,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |